Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
LDL receptor–mediated lipoprotein uptake fuels human CD4+ T cell polarization toward a c-MAF/IL-10– and FOXP3-driven phenotype
Angela Markovska, Niels S. van Heusden, Dagmar Duijzer, Alejandra Bodelón, Greta Rogani, Enric Mocholi, Edwin C.A. Stigter, Can Gulersonmez, Sander Kooijman, Leonie Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, Patrick C.N. Rensen, Jorg van Loosdregt, Sebastiaan J. Vastert, Noam Zelcer, Marianne Boes, Henk S. Schipper
Angela Markovska, Niels S. van Heusden, Dagmar Duijzer, Alejandra Bodelón, Greta Rogani, Enric Mocholi, Edwin C.A. Stigter, Can Gulersonmez, Sander Kooijman, Leonie Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, Patrick C.N. Rensen, Jorg van Loosdregt, Sebastiaan J. Vastert, Noam Zelcer, Marianne Boes, Henk S. Schipper
View: Text | PDF
Research Article Cell biology Immunology

LDL receptor–mediated lipoprotein uptake fuels human CD4+ T cell polarization toward a c-MAF/IL-10– and FOXP3-driven phenotype

  • Text
  • PDF
Abstract

Human CD4+ T cells utilize nutrients, including lipids, to support their activation and polarization. Considering the pivotal role of lipoproteins in lipid transport, we reasoned that lipoprotein uptake and processing could effect CD4+ T cell function. Here, we demonstrate that activation of human CD4+ T cells induced expression of LDL receptor (LDLR) to facilitate LDLR-mediated endocytosis of LDL. Degradation of surface LDLR on CD4+ T cells with PCSK9 hampered activation and proliferation of the cells. Lipoprotein deprivation or blocking of lysosomal cholesterol egress impaired activation of mechanistic target of rapamycin complex 1 (mTORC1), affecting CD4+ T cell activation and proliferation. Furthermore, lipoprotein deprivation of cultured primary CD4+ T cells lead to reduced expression of c-MAF and FOXP3, key transcription factors for IL-10, accompanied by reduced IL-10 secretion. The pivotal role of LDLR-mediated lipoprotein uptake for mTORC1 activity, c-MAF and FOXP3 expression, and IL-10 secretion was confirmed using LDLR-dysfunctional CD4+ T cells from patients with homozygous familial hypercholesterolemia. Our study offers valuable insights into the lipoprotein metabolism of human CD4+ T cells and their reliance on the LDLR pathway for activation and polarization, a feature that may be leveraged to modulate CD4+ T cell function.

Authors

Angela Markovska, Niels S. van Heusden, Dagmar Duijzer, Alejandra Bodelón, Greta Rogani, Enric Mocholi, Edwin C.A. Stigter, Can Gulersonmez, Sander Kooijman, Leonie Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, Patrick C.N. Rensen, Jorg van Loosdregt, Sebastiaan J. Vastert, Noam Zelcer, Marianne Boes, Henk S. Schipper

×

Figure 6

CD4+ T cells from patients with hoFH confirm a role of LDLR signaling for CD4+ T cell function.

Options: View larger image (or click on image) Download as PowerPoint
CD4+ T cells from patients with hoFH confirm a role of LDLR signaling fo...
(A) Schematic of LDLR protein domains and LDLRAP1, highlighting hoFH mutations (blue geometric shapes). (B) Cell surface LDLR expression on CD4+ T cells from patients with hoFH (n = 5) and individuals acting as healthy controls (HC) (n = 5). (C) Uptake of LDL-pHrodo measured by flow cytometry, where CD4+ T cells were activated for 24 hours, cultured for 2 hours in lipoprotein-deprived medium and 2 hours with LDL-pHrodo. Anti-LDLR (5 μg/mL) was added as indicated. One-way ANOVA with Šídák’s multiple comparisons test (****P < 0.0001; n = 5 HC and n = 5 hoFH). (D) Lipidome analysis of CD4+ T cell activated for 36 hours. The mean log2 values from HC (n = 5), hoFH (n = 5), and HC in lipoprotein-deprived conditions (n = 4) are shown. (E) CD4+ T cells from HCs (n = 5) and patients with hoFH (n = 5) were activated in vitro for 15 hours and qPCR was performed to measure the expression HMGCR, FASN, ABCA1, and VLDLR genes. Unpaired t tests (*P < 0.05, **P < 0.01). (F) pS6 measured with flow cytometry in CD4+ T cells after the indicated time of activation in CD4+ T cells from HC (n = 5) or individuals with hoFH (n = 4). Mann-Whitney U test (*P < 0.05). (G and H) MAF, FOXP3, TBX21, RORC, and IL10 mRNA levels in CD4+ T cells activated for 24 hours. Levels were normalized to RPL13A housekeeping gene and shown in relation to HC. Mann-Whitney U test (*P < 0.05; n = 5 HC and n = 4 hoFH). (I) Concentration of secreted cytokines IL-10, IFN-γ, and IL-17A by CD4+ T cells activated for 24 hours measured with ELISA. Mann-Whitney U tests (**P < 0.01; n = 5 HC and n = 5 hoFH). (J) CD4+ T cells were cultured under Treg-polarizing conditions (IL-2 and TGF-β) for 5 days. FOXP3 and CD127 expression was measured by flow cytometry. Mann-Whitney U test (*P < 0.05; n = 5 HC and n = 5 hoFH).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts